“The first human received a Neuralink implant yesterday, and is recovering well. Initial results show promising detection
of neuronal activity.
True to form, it was on in a human brain.
As always with Elon Musk, things move quickly.
In May 2023, the FDA (the American regulatory authority) granted Neuralink authorization to conduct its clinical trial which it had refused the previous year for reasons of device safety, without us knowing this. which motivated his change of mind.
Last September, the company announced (still on .
For this first study, Neuralink was looking for patients suffering from
“quadriplegia due to cervical spinal cord injury or
amyotrophic lateral sclerosis
(ALS or Charcot disease, Editor’s note)
”
.
96 probes of 32 electrodes each
Concretely, it involves implanting within the brain, in the regions which control movement, flexible wires covered with charged electrodes...
This article is reserved for subscribers.
You have 80% left to discover.
Flash sale
Unlock all items immediately.
I ENJOY IT
Already subscribed?
Log in